Stockreport

Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC

Vaccinex, Inc.  (VCNX) 
PDF ROCHESTER, N.Y., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treati [Read more]